Monday, May 11, 2026

Latest

Software Firm GitLab Prices US$800 Million IPO

Software company GitLab Inc. (Nasdaq: GTLB) started trading on the Nasdaq Global Select Market Thursday under the ticker symbol “GTLB”. The firm aims to raise US$800.8 million in its debut on the big board.

The offering consisted of 10.4 million Class A common shares at US$77.00 per share. The company is selling 8.42 million shares out of the offering while the remaining 1.98 million shares will be sold by the existing stockholder affiliated with GitLab CEO and chair Sytse Sijbrandij. GitLab said it will not receive any proceeds from the latter.

Goldman Sachs & Co., J.P. Morgan, and BofA Securities are acting as the lead bookrunners for the said offering. The underwriters were given a 30-day over-allotment option to purchase up to an additional 1.04 million shares at the same IPO price.

The offering is expected to close on October 18, 2021, subject to customary closing conditions.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Agnico Q1 Earnings Results Overshadowed By A Sinking Gold Price

Why More People Are Starting to Feel Broke | Darrell Thomas – VRIC Media

Newmont Q1 Earnings: A Billion In Free Cash Flow… A Month!

Recommended

Silver47 Pulls High-Grade Gold and Silver Assays from Nevada Vein Network At Kennedy

Canadian Gold Resources Taps Chernin as Interim CEO in Planned Transition

Related News

Cannabis SPAC Clover Leaf Capital Prices US$125 Million IPO

Special purpose acquisition company Clover Leaf Capital Corp. started trading its securities on the Nasdaq...

Tuesday, July 20, 2021, 04:46:00 PM

Semrush: The IPO Deep Dive

Semrush (NYSE: SEMR) is an online platform that offers a suite of tools to companies,...

Thursday, March 25, 2021, 12:31:00 PM

Cannabis-Focused Finance Company Altmore Capital Files For Nasdaq IPO

Specialty finance company Altmore BDC, Inc., also known as Altmore Capital, is looking to go...

Wednesday, February 9, 2022, 02:27:00 PM

Biopharmaceutical Firm Candel Therapeutics Prices Downsized US$72 Million IPO

Late clinical stage biopharmaceutical company Candel Therapeutics Inc. (Nasdaq: CADL) started publicly trading on the...

Tuesday, July 27, 2021, 10:47:00 AM

Biotech SPAC BioPlus Acquisition Prices US$200 Million IPO

Special purpose acquisition company BioPlus Acquisition Corp. (Nasdaq: BIOSU) started trading publicly on the Nasdaq...

Monday, December 6, 2021, 02:19:00 PM